Accessibility Menu
Psyched Wellness logo

Psyched Wellness(OTC) PSYCF

Market Cap$2.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-97%
5 Year-96%
1 Year-46%
1 Month-1%
$0.00
-40.00%
-0.00Today
Psyched Wellness last closing stock price
MetricPriceDate
Last closeUSD 0.012026-08-03
Psyched Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+14.75%USD 0.012026-07-27
1 month-1.41%USD 0.012026-06-30
3 month-31.37%USD 0.012026-05-05
Year to date-22.22%USD 0.012025-12-31
1 year-46.15%USD 0.012025-07-31
3 year-84.78%USD 0.052023-08-04
5 year-95.88%USD 0.172021-08-04
Since inception-96.5%USD 0.202020-05-06

Psyched Wellness Financials at a Glance

Market Cap

$2.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$746.27K

Net Income (TTM)

-CA$5.37M

EPS (TTM)

-$0.01

P/E Ratio

-0.56

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$0.00

Volume

90,300

Open

$0.01

Previous Close

$0.00

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Apr 28, 2025

PSYCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Psyched Wellness

Psyched Wellness Ltd. is a health supplements company focused on producing and distributing mushroom-derived products in the United States. The company offers a range of Amanita Muscaria-derived extracts, teas, and capsules aimed at promoting stress relief and relaxation.

Products and Services
  • Amanita Muscaria-derived water-based extracts
  • Teas designed for relaxation and restful sleep
  • Capsules for stress relief and wellness
Growth Outlook
  • Market demand for natural wellness products is increasing
  • Expansion into online sales channels enhances accessibility
  • Focus on research and development to innovate product offerings
Financial Highlights
  • Recent quarterly revenue of 237,053 CAD shows growth potential
  • Cash and cash equivalents of 751,457 CAD provide liquidity
  • Current ratio of 5.04 indicates strong short-term financial health
Psyched Wellness Ltd. operates in the growing sector of health supplements, particularly focusing on the benefits of mushroom-derived products. The company's innovative approach to wellness aligns with current consumer trends favoring natural and holistic health solutions. With a strong emphasis on research and development, Psyched Wellness aims to expand its product line and enhance its market presence. Recent financial data indicates a positive trajectory, with increasing revenue and a solid cash position, suggesting potential for future growth. The company's strategic focus on online sales channels further positions it to capitalize on the expanding market for health supplements.
AI Generated • Jul 23, 2026

Industry

Personal Products

CEO

Jeff Stevens

Headquarters

Toronto, ON M5C 2C5, CA

PSYCF Financials

Key Financial Metrics (TTM)

Gross Margin

-82.84%

Operating Margin

-761.26%

Net Income Margin

-719.79%

Return on Equity

-196.58%

Return on Capital

-166.36%

Return on Assets

-263.48%

Earnings Yield

-1.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

407.72M

Volume

90.30K

Avg. Volume

111.32K

Financials (TTM)

Gross Profit

-CA$435.41K

Operating Income

-CA$5.76M

EBITDA

-CA$5.75M

Operating Cash Flow

-CA$4.42M

Capital Expenditure

CA$4.14

Free Cash Flow

-CA$4.42M

Cash & ST Invst.

CA$605.43K

Total Debt

CA$0.00

Psyched Wellness Performance Analysis

Psyched Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30CAD 11,021N/A
20232023-11-30CAD 237,6592056.4%
20242024-11-30CAD 457,11292.3%
20252025-11-30CAD 337,099-26.3%
Psyched Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-08-31146.5%
Q42025-11-3028.0%
Q12026-02-2827.5%
Q22026-05-31-24.9%
Psyched Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30CAD -0.02-14.6%
20232023-11-30CAD -0.02-36.2%
20242024-11-30CAD -0.01-15.9%
20252025-11-30CAD -0.01-6.1%
Psyched Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-08-3135.5%
Q42025-11-30-7.5%
Q12026-02-28-7.0%
Q22026-05-3110.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$177.94K

+201.8%

Gross Profit

-CA$299.30K

-1338.3%

Gross Margin

-1.68%

N/A

Market Cap

$2.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$26.92K

N/A

Employees

106

N/A

Net Income

-CA$1.62M

+9.2%

EBITDA

-CA$1.63M

-18.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$605.43K

-86.4%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$40.98K

-36.4%

Inventory

CA$1.37M

+88.7%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

N/A

Return on Assets

-2.63%

N/A

Return on Invested Capital

-3.36%

N/A

Free Cash Flow

-CA$930.62K

+42.5%

Operating Cash Flow

-CA$930.62K

+42.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RELVReliv' International, Inc.
$1.83+0.00%
TOFBTofutti Brands Inc.
$0.65+0.00%
CYANCyanotech Corporation
$0.53+0.00%
SNBHSentient Brands Holdings Inc.
$0.28+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About PSYCF

What is the current price of Psyched Wellness?

Psyched Wellness is trading at $0.00 per share.

What is the 52-week range for Psyched Wellness?

Over the past 52 weeks, Psyched Wellness has traded between $0.00 and $0.02.

How much debt does Psyched Wellness have?

As of the most recent reporting period, Psyched Wellness reported total debt of CA$0.00.

How much cash does Psyched Wellness have on hand?

Psyched Wellness reported CA$439.22K in cash and cash equivalents in its most recent financial results.

What is Psyched Wellness’s dividend yield?

Psyched Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.